Mushrooms Inc (MSRM)

[Sjam410]

Ouch someone decided to dump. Looks like we'll dip back into the 2s afterall

[fenixinvest]

Terrible management

[Sjam410]

That was the detail I was glad was included as well because it wasn't clear to me either. So many possible infections and can't test them all. Now I'm more curious how they'll actually work. I want to see the patent lol

[Jt2228]

I like that it had more specific about what the bandages address. I was a little unclear on the specifics. Probably missed it before. All I heard before was some kind bacterial detection bandage.

"We are addressing the increasing E. coli and MRSA threats in healthcare settings. The escalating crisis of
antibiotic-resistant infections, with AMR responsible for 1.27 million global deaths in 2019 and projected to
cause up to 10 million deaths annually by 2050, heightens the need for our advanced solutions."

[rmclau4493]

Yes I did. Really looks good transparent. She needs to do PRs on what the are doing.

[2times2]

Mushrooms Inc

Attachments12:28?PM (49 minutes ago)

to Mushrooms

Good Day from Mushrooms Inc,



We trust this message finds you in good spirits and health.



We created a new tab on our website called NEWSLETTERS. This is where we will post monthly insights on our previously announced projects, answers to shareholder questions we have received, video links and other updates that are not worthy of full SEC publication. While SEC announcements are reserved for material information that may affect investment decisions or stock values, our newsletters are crafted to provide shareholders and interested parties with a more detailed and nuanced view of our operations, innovations, and milestones which have been previously announced. They are a window into the day-to-day advancements that fuel the growth and evolution of Mushrooms Inc. For the most significant updates with regulatory implications, please refer to our official filings with the SEC found on the tab that was previously called NEWS but is now called PUBLIC ANNOUNCEMENTS.



The January Newsletter can be viewed by clicking HERE.



We have also attached it for your convenience.



As always, we appreciate your continued support and interest in Mushrooms Inc.



Please reach out with any questions, comments, or suggestions, and we will be sure to review them.





Mushrooms Inc.

signature_2135367602

[Sjam410]

Anyone else get their new newsletter that was just sent out? I thought it was interesting

[Sjam410]

Unrestricted now up to 8.3M. Gone up a million over the last month or so

[sand]

We got a great team here - brick by brick

[i_like_bb_stock]

Doubt there’s much there we need volume

[fenixinvest]

OTCN and CFGN are rough

[i_like_bb_stock]

Yea hope we see something about some production and marketing soon

[Sjam410]

At least it seems to have found its bottom at the current range. Will probably hover around here for a while

[i_like_bb_stock]

who knows float is tiny

[Sjam410]

Just throwing this out to the board. Another potential disrupter is ELTP. If they're not on your radar I'd check them out. It's already up a lot this year, but similar to msrm I have no plans to sell anytime soon. I got in around .11 but was watching for a while.

They have a generic Adderall that they just started selling, but what im really excited about is a product they're making called SequestOx that isn't approved yet, but I think could be huge if it does get approved. It's basically an opioid for pain, but wrapped in naltrexone. Naltrexone is a medicine to help prevent addiction, so if approved I could see it being very popular.

They've had some issues getting it approved but are rolling out other products as well.

Just wanted to throw it out there, but of course do whatever you want and do some DD if interested. Have a good weekend everyone.

[Sjam410]

It was like 7.3 million or something now it shows 7.9

[Sjam410]

I'm confused - otc site shows unrestricted increased by a few hundred thousand. What am I missing?

[i_like_bb_stock]

yes we need catlysts

[i_like_bb_stock]

well should be 4M less shares available free trading

[Jt2228]

What do you make of that? How does that affect the current tradable stock?

[rmclau4493]

Really strange after the CEO recent post on having a low OS creating stability. Would be nice if we could generate some interest

[i_like_bb_stock]

$MSRM interesting 4.2M shares moved from unrestricted to restricted pic.twitter.com/6Mtj9b8nxd

— i_like_bb_stock (@thommic) January 12, 2024

[Sjam410]

Now we just need that upward trajectory to play out lol

[Sjam410]

Nice - thanks!

[2times2]

View profile for Kimberly - ZAWI - Carlson
Kimberly - ZAWI - Carlson

CEO @ Mushrooms Inc. | Research, Innovation, Health, Collaboration
3h

Exploring the OTC Landscape: Insights from Mushrooms Inc.

As the CEO of a burgeoning public company on the OTC market, I've delved deep into the complexities of public trading to sculpt a startup that thrives in this space. I'm excited to share insights from my journey, especially how they pertain to Mushrooms Inc., starting with the concept of Outstanding Shares.

📈 Stability and growth potential are paramount in OTC markets. #MushroomsInc stands out with its low outstanding shares, balancing stock stability with investor influence. Our biotech innovations and investor-centric philosophy distinguish us in the mushroom sector. #OTCInvesting

The Significance of Low Outstanding Shares:
In the fluid world of Over-the-Counter trading, where investors seek both stability and growth, Mushrooms Inc. makes a compelling case with its low outstanding shares. But why is this noteworthy for investors?

Understanding Outstanding Shares:
Outstanding shares represent the aggregate of a company's stock held by all shareholders, inclusive of institutional entities and internal officers. A modest count of outstanding shares often signals the potential for stock stability and augmented investor sway. For Mushrooms Inc., our valuation paints an intriguing picture against the backdrop of our patented technologies.

Our strategy of maintaining fewer outstanding shares is intentional, mirroring our commitment to an investor-friendly climate. In the present scenario, this contributes to stock price sensitivity to market trades.

It's vital for shareholders to grasp that even modest investments can materially affect our stock price. Conversely, a sell-off could also leave a noticeable imprint. However, as we forge ahead with innovations like our bacterial detection bandage, our stock's behavior may shift. We're on an upward trajectory, fueled by growth and novelty, and our fiscal tactics will evolve to align with our advancements. Yet, our focus on the correlation between outstanding shares, revenue, and growth remains steadfast.

Benefits for Investors:
Investors in entities with scant outstanding shares, such as Mushrooms Inc., may benefit from pronounced influence and a heightened demand prospect.

Understanding the dynamics of outstanding shares is crucial in the OTC market. Mushrooms Inc. stands as a prime example of how low outstanding shares can offer a unique and potentially rewarding investment opportunity. $MSRM #Mushroomsinc

https://zurl.co/1mck

[RIOgrande44]

That's good to hear!

[2times2]

Reassuring new tweet (upon concern expressed about SS preservation):

Mushrooms Inc. @MushroomsInc
Stability & growth are key in OTC markets. 📈 #MSRM exemplifies this with low outstanding shares, offering stock stability & investor control. Our biotech innovations & investor-friendly approach make us a standout in the mushroom industry. #OTCInvesting
https://zurl.co/1mck

[i_like_bb_stock]

Hasn’t been much volume we need a catalyst hoping 2024 is our year

[fenixinvest]

still a low float at 7 million according to OTC. Need CFGN and those new shares out of the way

[sand]

Noticed that too Interesting. Very low vol. Can move with large vol. I hope everyone has a safe healthy prosperous kind new year. Good group here.

[Sjam410]

Lol someone determined to not let it close at 4. Selling 200 shares at a time to get it a little lower 🙄

[2times2]

Yes, Happy holidays to all. Santa seems to be a little late for MSRMers even though we have been good but I am sure the Easter bunny will come with a lot of goodies for us...and Santa will double-stack next XMas

[Sjam410]

You too!

[sand]

Hope everyone here has a very healthy prosperous and loving holiday we have good group here

[Sjam410]

Nice to see someone bit at the 5's that's more than like a 200 share trade

[Sjam410]

Good stuff. Thanks

[sand]

Thanks 2times for relaying that. Good to see you. Have a good team here.

[2times2]

The CEO explained that some "legacy holders" (previous management) converted from restricted to unrestricted and that she has no control over that, BUT that it was communicated that it will cease - and, indeed, now for months the unrestricted stayed at 7.1M.

[Sjam410]

Been 7.1 for a while

[gains4us]

Unrestricted at 7.1M now - were at 2.6M same time last year

[Sjam410]

Now we need someone to bite at the 4's

[Sjam410]

There goes the 298k. Glad that's out of the way

[Sjam410]

Yea a little annoying, but at least the spread is narrow and not like 2 cents like it had been

[sand]

mm's not showing ask might be same as yesterday of around 290k

[sand]

meant the ma200 on weekly as next resist after the .25 mark was thiiinking of another chart

[sand]

agree the ma50 looms as first major resistance after that or not

[Sjam410]

And thats just to break even...

[sand]

They must think enough of the price to put the 25 cent mark.

[Sjam410]

She did actually reply to me today anyways and sounds like things are in motion. She added that she does care as much about the price as we do, it's just out of her control so "onward and upward with optimism is where I am at." In terms of moving forward with the plan described on the stock day stream

[sand]

Makes sense. Always good to develop a good relationship with the company.